Leslie Ziegler Schrock

2 weeks ago | secondopinion.media | Christina Farr |Leslie Ziegler Schrock

This post is Part III of a three-part series by Carolyn Witte (Founder of Tia Health) and Leslie Schrock co-published on Second Opinion and The XX Factor to help women’s health founders raise money in the rapidly growing but still nascent women’s health category. Our goal is to offer a practical, founder-first framework to help you decide if, when, and how to raise venture—and what to do if that’s not the best path for you.

3 weeks ago | secondopinion.media | Christina Farr |Leslie Ziegler Schrock

This post is Part II of a three-part series by Carolyn Witte and Leslie Schrock co-published on Second Opinion and The XX Factor to help women’s health founders raise money in the rapidly growing but still nascent women’s health category. Our goal is to offer a practical, founder-first framework to help you decide if, when, and how to raise venture—and what to do if that’s not the best path for you. ICYMI, Part I covers the foundational question: Is your business venture-backable?

1 month ago | secondopinion.media | Christina Farr |Leslie Ziegler Schrock

This post is Part I of a three-part series by Carolyn Witte and Leslie Schrock co-published on Second Opinion and The XX Factor, created to help women’s health founders raise money in the rapidly growing women’s health category. Our goal is to offer a practical, founder-first framework to help you decide if, when, and how to raise venture—and what to do if that’s not the best path for you.

1 month ago | secondopinion.media | Christina Farr |Leslie Ziegler Schrock

A staggering one in eight Americans has tried GLP-1s. We know that, in addition to weight loss, they also help reduce the risk of conditions like type 2 diabetes and cardiovascular disease, and have a role in preventing neurodegenerative diseases like Alzheimer’s or Parkinson’s. But GLP-1 use impacts a common and less discussed condition—binge eating. And the effects are transforming big food. As a former food entrepreneur, I know more than I wish I did about that profoundly flawed system.

Feb 6, 2025 | secondopinion.media | Leslie Ziegler Schrock |Christina Farr

This edition of Second Opinion is sponsored by: Seraphina Therapeutics is a health and wellness company dedicated to improving global health by discovering and developing essential fatty acid therapeutics to slow aging, extend wellness, and prevent, manage, and treat chronic diseases. The quest to defy death makes splashy headlines for extremes like billionaire blood boys and Brian Johnson’s $2M annual body optimization budget.